CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Sébastien Chénier¹, Grace Yoon², Bob Argiropoulos³, Julie Lauzon³, Rachel Laframboise⁴, Joo Wook Ahn⁵, Caroline Mackie Ogilvie⁵, Anath C Lionel⁶, Christian R Marshall⁶, Andrea K Vaags⁷, Bita Hashemi², Karine Boisvert⁴, Géraldine Mathonnet⁸, Frédérique Tihy⁸, Joyce So⁹, Stephen W Scherer⁶, Emmanuelle Lemyre⁸, Dimitri J Stavropoulos¹⁰

Affiliations

¹ Division of Medical Genetics, Department of Pediatrics, Centre Hospitalier Universitaire de Sherbrooke, 3001, 12E Avenue Nord, Sherbrooke, QC J1H 5N4, Canada.
² Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, 555 University Ave, Toronto, ON M5G 1X8, Canada.
³ Department of Medical Genetics, Alberta Children's Hospital Research Institute, University of Calgary, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.
⁴ Division of Medical Genetics, Department of Pediatrics, Centre Hospitalier Universitaire de Québec, 2705 Boulevard Laurier, Québec, QC G1V 4G2, Canada.
⁵ Cytogenetics Department, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.
⁶ Department of Molecular Genetics and McLaughlin Centre, The Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children and University of Toronto, 686 Bay Street, Toronto, ON M5G 0A4, Canada.
⁷ Division of Anatomic Pathology and Cytopathology, Cytogenetics Laboratory, Calgary Laboratory Service and Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.
⁸ Division of Medical Genetics, Department of Pediatrics, Centre Hospitalier Universitaire de Sainte-Justine, Université de Montréal, 3175, Chemin de la Côte-Sainte-Catherine, Montréal, QC H3T 1C5, Canada.
⁹ Department of Clinical Genetics, Lakeridge Health Oshawa, 1 Hospital Court, Oshawa, ON L1G 2B9, Canada.
¹⁰ Department of Paediatric Laboratory Medicine, The Hospital for Sick Children and University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada.

PMID: 24834135
PMCID: PMC4022362
DOI: 10.1186/1866-1955-6-9

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Sébastien Chénier et al. J Neurodev Disord. 2014.

. 2014;6(1):9.

doi: 10.1186/1866-1955-6-9. Epub 2014 Apr 22.

Authors

Affiliations

¹ Division of Medical Genetics, Department of Pediatrics, Centre Hospitalier Universitaire de Sherbrooke, 3001, 12E Avenue Nord, Sherbrooke, QC J1H 5N4, Canada.
² Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, 555 University Ave, Toronto, ON M5G 1X8, Canada.
³ Department of Medical Genetics, Alberta Children's Hospital Research Institute, University of Calgary, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.
⁴ Division of Medical Genetics, Department of Pediatrics, Centre Hospitalier Universitaire de Québec, 2705 Boulevard Laurier, Québec, QC G1V 4G2, Canada.
⁵ Cytogenetics Department, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.
⁶ Department of Molecular Genetics and McLaughlin Centre, The Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children and University of Toronto, 686 Bay Street, Toronto, ON M5G 0A4, Canada.
⁷ Division of Anatomic Pathology and Cytopathology, Cytogenetics Laboratory, Calgary Laboratory Service and Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.
⁸ Division of Medical Genetics, Department of Pediatrics, Centre Hospitalier Universitaire de Sainte-Justine, Université de Montréal, 3175, Chemin de la Côte-Sainte-Catherine, Montréal, QC H3T 1C5, Canada.
⁹ Department of Clinical Genetics, Lakeridge Health Oshawa, 1 Hospital Court, Oshawa, ON L1G 2B9, Canada.
¹⁰ Department of Paediatric Laboratory Medicine, The Hospital for Sick Children and University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada.

PMID: 24834135
PMCID: PMC4022362
DOI: 10.1186/1866-1955-6-9

Abstract

Background: The chromodomain helicase DNA binding domain (CHD) proteins modulate gene expression via their ability to remodel chromatin structure and influence histone acetylation. Recent studies have shown that CHD2 protein plays a critical role in embryonic development, tumor suppression and survival. Like other genes encoding members of the CHD family, pathogenic mutations in the CHD2 gene are expected to be implicated in human disease. In fact, there is emerging evidence suggesting that CHD2 might contribute to a broad spectrum of neurodevelopmental disorders. Despite growing evidence, a description of the full phenotypic spectrum of this condition is lacking.

Methods: We conducted a multicentre study to identify and characterise the clinical features associated with haploinsufficiency of CHD2. Patients with deletions of this gene were identified from among broadly ascertained clinical cohorts undergoing genomic microarray analysis for developmental delay, congenital anomalies and/or autism spectrum disorder.

Results: Detailed clinical assessments by clinical geneticists showed recurrent clinical symptoms, including developmental delay, intellectual disability, epilepsy, behavioural problems and autism-like features without characteristic facial gestalt or brain malformations observed on magnetic resonance imaging scans. Parental analysis showed that the deletions affecting CHD2 were de novo in all four patients, and analysis of high-resolution microarray data derived from 26,826 unaffected controls showed no deletions of this gene.

Conclusions: The results of this study, in addition to our review of the literature, support a causative role of CHD2 haploinsufficiency in developmental delay, intellectual disability, epilepsy and behavioural problems, with phenotypic variability between individuals.

Keywords: Autism spectrum disorder; CHD2; Developmental delay; Epilepsy; Learning disability.

PubMed Disclaimer

Figures

**Figure 1**
Summary of deletions observed in our patients and reported in the literature.

See this image and copyright information in PMC

References

1. Hall JA, Georgel PT. CHD proteins: a diverse family with strong ties. Biochem Cell Biol. 2007;85:463–476. doi: 10.1139/O07-063. - DOI - PubMed
1. Tsukiyama T. The in vivo functions of ATP-dependent chromatin-remodelling factors. Nat Rev Mol Cell Biol. 2002;3:422–429. doi: 10.1038/nrm828. - DOI - PubMed
1. Smith CL, Peterson CL. ATP-dependent chromatin remodeling. Curr Top Dev Biol. 2005;65:115–148. - PubMed
1. Tajul-Arifin K, Teasdale R, Ravasi T, Hume DA, Mattick JS. RIKEN GER Group, GSL Members. Identification and analysis of chromodomain-containing proteins encoded in the mouse transcriptome. Genome Res. 2003;13:1416–1429. doi: 10.1101/gr.1015703. - DOI - PMC - PubMed
1. Marfella CGA, Imbalzano AN. The Chd family of chromatin remodelers. Mutat Res. 2007;618:30–40. doi: 10.1016/j.mrfmmm.2006.07.012. - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Affiliations

CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems

Authors

Affiliations

Abstract

Figures

References

LinkOut - more resources

Full Text Sources

Other Literature Sources